Fortress Biotech, Inc. Adjustments to Additional Paid in Capital, Other
Fortress Biotech, Inc. (FBIO) reported Adjustments to Additional Paid in Capital, Other of $314.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-18.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2019-03-18
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for the quarter ending 2017-09-30 was $0.00.
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for the quarter ending 2016-12-31 was $125.00K.
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for the quarter ending 2011-12-31 was $0.00.
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for fiscal 2017 was $314.00K, a 84.35% decline from fiscal 2016.
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for fiscal 2016 was $2.01M.
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for fiscal 2011 was $30.00K, a 25.00% decline from fiscal 2010.
- Fortress Biotech, Inc. adjustments to additional paid in capital, other for fiscal 2010 was $40.00K, a 0.00% change from fiscal 2009.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $314.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $314.00K 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | $314.00K 10-Q · filed 2017-08-09 | |||
| 2016-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $2.01M 10-K · filed 2018-03-16 | ||
| 2016-09-30 | $1.88M 10-Q · filed 2016-11-09 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $30.00K 10-K · filed 2014-03-14 | ||
| 2011-09-30 | $30.00K 10-Q · filed 2011-11-14 | |||
| 2010-12-31 | $40.00K 10-K · filed 2014-03-14 | |||
| 2009-12-31 | $40.00K 10-K · filed 2014-03-14 | |||
| 2008-12-31 | $20.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |